Study Overview
Sakellaris et al. (2006) conducted a pilot study examining the effects of creatine supplementation in children who had sustained traumatic brain injuries (TBI).
Building on preclinical evidence from Sullivan et al. (2000) showing neuroprotective effects of creatine in animal models, this was one of the first clinical studies to test creatine’s potential in human brain injury recovery (Sakellaris et al., 2006) .
Key Findings
- Reduced duration of post-traumatic amnesia: Children receiving creatine showed shorter periods of post-traumatic amnesia compared to control groups
- Improved cognitive recovery: Cognitive assessment scores improved more rapidly in the creatine-supplemented group
- Shorter ICU stays: The creatine group tended to have shorter intensive care unit stays, suggesting faster stabilization
- Fewer complications: There were fewer instances of headache, dizziness, and fatigue in the creatine group during the recovery period
- Safe and well-tolerated: Creatine supplementation was well-tolerated in the pediatric population with no reported adverse effects
Practical Implications
While this study is preliminary, it opens an exciting avenue for creatine research beyond sports performance.
Traumatic brain injury is a leading cause of death and disability in children worldwide, including in Malaysia where road traffic accidents remain a significant pediatric health concern.
The finding that creatine may support brain recovery adds to the growing body of evidence for creatine’s neuroprotective properties.
However, it is essential to note that this was a small pilot study, and creatine should not be self-administered as a TBI treatment without medical supervision.
Larger, well-designed clinical trials are needed before creatine can be recommended as part of standard TBI management protocols.
Study Limitations
- Small sample size limits the statistical power and generalizability of findings
- The study was not double-blinded in the strictest sense, which could introduce bias
- Dosing protocols for pediatric TBI patients have not been optimized
- Long-term follow-up data was limited, and it is unclear whether early benefits persisted
- The control group did not receive a matched placebo in all cases
Where This Fits in the Evidence
Sakellaris et al. (2006) is a small pilot that carried preclinical work into the clinic, testing in children with traumatic brain injury an idea that animal models from Sullivan et al. (2000) had suggested — that creatine might cushion the brain’s energy crisis after injury. The reported signals are encouraging, with shorter post-traumatic amnesia, faster cognitive recovery and fewer complications, but the sample is small and the blinding imperfect, so it points towards larger trials rather than treatment. Its real significance is as an early human marker on the neuroprotection branch of the creatine evidence base, distinct from the much firmer ground in healthy and ageing populations. The wider body of work is collected in our research library.
Sources & References
This page summarizes Sakellaris et al. (2006).
Full citation: Sakellaris G, Kotsiou M, Tamiolaki M, Kalostos G, Tsapaki E, Spanaki M, Spilioti M, Charissis G, Evangeliou A. Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration. Journal of Trauma.
2006;61(2):322-329. doi:10.1097/01.ta.0000230269.55313.ca
What This Means for You
This is a clinical pilot, so the honest takeaway is awareness rather than action: the encouraging recovery signals in injured children occurred under hospital care and do not translate into anything to do at home. Creatine is not an approved treatment for brain injury, and a child’s head injury is emphatically a matter for doctors, not a supplement bought online. If you are interested in creatine’s neuroprotective research more broadly, read this as a promising direction still awaiting larger trials.